DAOBOOST Trademark

Trademark Overview

On Wednesday, December 6, 2023, a trademark application was filed for DAOBOOST with the United States Patent and Trademark Office. The USPTO has given the DAOBOOST trademark a serial number of 98302132. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Friday, September 6, 2024. This trademark is owned by STADA Arzneimittel AG. The DAOBOOST trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of Histamine Intolerance containing diamine oxidase enzymes; chemico-pharmaceutical pharmaceutical preparations for the treatment of Histamine Intolerance, containing diamine oxidase enzymes; sanitary preparations for medical purposes featuring diamine oxidase enzymes; biological preparations for medical purposes, namely, for the treatment of Histamine Intolerance, containing diamine oxidase enzymes; chemical preparations for medical purposes, namely, for the treatment of Histamine Intolerance, containing diamine oxidase enzymes; diamine oxidase enzymes and diamine oxidase enzyme preparations for medical purposes; dietetic foods adapted for medical purposes containing diamine oxidase enzymes; diagnostic preparations for medical purposes containing diamine oxidase enzymes; chemical reagents for medical purposes containing diamine oxidase enzymes; nutritional additives for medical purposes for use in foods and dietary supplements for human co...
daoboost

General Information

Serial Number98302132
Word MarkDAOBOOST
Filing DateWednesday, December 6, 2023
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateFriday, September 6, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of Histamine Intolerance containing diamine oxidase enzymes; chemico-pharmaceutical pharmaceutical preparations for the treatment of Histamine Intolerance, containing diamine oxidase enzymes; sanitary preparations for medical purposes featuring diamine oxidase enzymes; biological preparations for medical purposes, namely, for the treatment of Histamine Intolerance, containing diamine oxidase enzymes; chemical preparations for medical purposes, namely, for the treatment of Histamine Intolerance, containing diamine oxidase enzymes; diamine oxidase enzymes and diamine oxidase enzyme preparations for medical purposes; dietetic foods adapted for medical purposes containing diamine oxidase enzymes; diagnostic preparations for medical purposes containing diamine oxidase enzymes; chemical reagents for medical purposes containing diamine oxidase enzymes; nutritional additives for medical purposes for use in foods and dietary supplements for human consumption, containing diamine oxidase enzymes; nutritional additives to foodstuffs for animals for medical purposes containing diamine oxidase enzymes

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, December 6, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSTADA Arzneimittel AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBad Vilbel 61118
DE

Trademark Events

Event DateEvent Description
Monday, March 4, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, June 25, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, June 25, 2024ASSIGNED TO EXAMINER
Wednesday, December 6, 2023NEW APPLICATION ENTERED
Tuesday, June 25, 2024NON-FINAL ACTION E-MAILED
Tuesday, June 25, 2024NON-FINAL ACTION WRITTEN
Friday, September 6, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, September 6, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 6, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED

Related Keywords

daoboost oxidase diamine enzymes medical purposes preparations containing histamine treatment intolerance